Strumento inattivo

Azioni Celator Pharmaceuticals Inc

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

Brower Piven Commences An Investigation Into The Proposed Sale Of Celator Pharmaceuticals, Inc. And Encourages Shareholders To Contact The Firm For Additional Information	14/06/16
CELATOR PHARMACEUTICALS, INC. Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Jazz Pharmaceuticals plc	02/06/16
Celator Pharmaceuticals : Jazz Pharma to buy Celator in $1.5 billion deal	31/05/16
Celator Pharmaceuticals : Jazz Pharma nears deal to buy Celator for about $1.5 billion - WSJ	31/05/16
Steve Cohen’s Point72 says it has perfect U.S. compliance	18/03/16

Dirigenti	Titolo	Età	Da
Arthur C. Louie CTO	Chief Tech/Sci/R&D Officer	-	-

Settore

	Variaz. 1 gen.	Capi.
IQVIA HOLDINGS INC.	+1,51%	42,75 Mrd
MODERNA, INC.	+8,57%	41,34 Mrd
LONZA GROUP AG	+49,22%	41,61 Mrd
CELLTRION, INC.	-12,36%	26,59 Mrd
ICON PUBLIC LIMITED COMPANY	+8,92%	25,49 Mrd
ALNYLAM PHARMACEUTICALS, INC.	-25,13%	18,12 Mrd
MEDPACE HOLDINGS, INC.	+29,17%	12,24 Mrd
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3,12%	11,76 Mrd
UNITED THERAPEUTICS CORPORATION	+6,35%	11 Mrd